Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Harte Hanks (HHS) Other Operating Expenses (2018 - 2025)

Harte Hanks has reported Other Operating Expenses over the past 15 years, most recently at $33.3 million for Q4 2025.

  • Quarterly Other Operating Expenses fell 21.32% to $33.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $111.6 million through Dec 2025, up 6.26% year-over-year, with the annual reading at $131.1 million for FY2025, 15.13% down from the prior year.
  • Other Operating Expenses was $33.3 million for Q4 2025 at Harte Hanks, up from $32.1 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $43.6 million in Q3 2022 and troughed at -$66.8 million in Q4 2023.
  • The 5-year median for Other Operating Expenses is $38.2 million (2022), against an average of $29.4 million.
  • Year-over-year, Other Operating Expenses plummeted 254.41% in 2023 and then surged 194.97% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at $42.0 million in 2021, then rose by 2.94% to $43.2 million in 2022, then plummeted by 254.41% to -$66.8 million in 2023, then soared by 163.32% to $42.3 million in 2024, then dropped by 21.32% to $33.3 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Other Operating Expenses are $33.3 million (Q4 2025), $32.1 million (Q3 2025), and $11.2 million (Q2 2025).